TR200201146T2 - Sertralin hidrokorid polimorfik formları. - Google Patents
Sertralin hidrokorid polimorfik formları.Info
- Publication number
- TR200201146T2 TR200201146T2 TR2002/01146T TR200201146T TR200201146T2 TR 200201146 T2 TR200201146 T2 TR 200201146T2 TR 2002/01146 T TR2002/01146 T TR 2002/01146T TR 200201146 T TR200201146 T TR 200201146T TR 200201146 T2 TR200201146 T2 TR 200201146T2
- Authority
- TR
- Turkey
- Prior art keywords
- sertraline
- hydrocoride
- sertraline hydrochloride
- polymorphic forms
- polymorphic
- Prior art date
Links
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
- 229960002073 sertraline Drugs 0.000 title 1
- GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 abstract 3
- 229960003660 sertraline hydrochloride Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99810981 | 1999-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200201146T2 true TR200201146T2 (tr) | 2004-12-21 |
Family
ID=8243113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/01146T TR200201146T2 (tr) | 1999-10-29 | 2000-10-23 | Sertralin hidrokorid polimorfik formları. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6872853B1 (https=) |
| EP (1) | EP1224160B1 (https=) |
| JP (1) | JP2003513062A (https=) |
| CN (1) | CN1384816A (https=) |
| AR (1) | AR026293A1 (https=) |
| AT (1) | ATE409684T1 (https=) |
| AU (1) | AU1386301A (https=) |
| CA (1) | CA2387135A1 (https=) |
| DE (1) | DE60040406D1 (https=) |
| HU (1) | HUP0203559A3 (https=) |
| IL (2) | IL149050A0 (https=) |
| MX (1) | MXPA02004255A (https=) |
| MY (1) | MY141509A (https=) |
| TR (1) | TR200201146T2 (https=) |
| TW (1) | TWI260315B (https=) |
| WO (1) | WO2001032601A1 (https=) |
| ZA (1) | ZA200203254B (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500987B1 (en) * | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| HK1040979A1 (zh) * | 1998-11-27 | 2002-06-28 | Teva Pharmaceutical Industries Ltd. | 盐酸舍曲林多晶型物 |
| EP1632474A1 (en) * | 1998-11-27 | 2006-03-08 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| US7442838B2 (en) * | 1999-10-29 | 2008-10-28 | Ciba Specialty Chemicals Corp. | Polymorphic forms of sertraline hydrochloride |
| US20050119351A1 (en) * | 1999-10-29 | 2005-06-02 | Van Der Schaaf Paul A. | Polymorphic forms of sertraline hydrochloride |
| EP1774965A3 (en) * | 1999-12-21 | 2007-10-10 | Teva Pharmaceutical Industries Ltd | Novel sertraline hydrochloride polymorph, processes for preparing them, compositions containing them and methods of using them |
| ES2281374T3 (es) * | 1999-12-21 | 2007-10-01 | Teva Pharmaceutical Industries Ltd. | Nuevos polimorfos de hidrocloruro de sertralina, procedimientos para su preparacion, composiciones que los contienen y metodos para su utilizacion. |
| IN192343B (https=) * | 2000-05-26 | 2004-04-10 | Ranbaxy Lab Ltd | |
| CA2448279A1 (en) | 2001-05-31 | 2002-12-05 | Orion Corporation Fermion | Process for preparing sertraline hydrochloride polymorphic form ii |
| AU2003251290A1 (en) * | 2002-04-29 | 2003-11-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
| MXPA04011375A (es) * | 2002-06-27 | 2005-02-14 | Interdigital Tech Corp | Controlador de red de radio para intercambio de informacion de equipo. |
| WO2005000786A1 (en) | 2003-05-23 | 2005-01-06 | Transform Pharmaceuticals, Inc. | Sertraline compositions |
| JP4791970B2 (ja) | 2003-11-04 | 2011-10-12 | シプラ・リミテッド | 選択的セロトニン再取込み阻害剤の多形体の製造方法 |
| EP1711493A2 (en) * | 2004-02-06 | 2006-10-18 | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement | Crystalline forms of zolmitriptan |
| EP1893559A2 (en) * | 2005-06-09 | 2008-03-05 | Teva Pharmaceutical Industries Ltd | Process for preparation of sertraline hydrochloride form i |
| US7518019B2 (en) | 2006-06-01 | 2009-04-14 | Hetero Drugs Limited | Processes for preparing sertraline hydrochloride crystalline forms |
| CA2594198A1 (en) * | 2007-07-20 | 2009-01-20 | Apotex Pharmachem Inc. | A novel process for the preparation of sertraline hydrochloride form ii |
| US9993793B2 (en) | 2010-04-28 | 2018-06-12 | The Procter & Gamble Company | Delivery particles |
| US9186642B2 (en) | 2010-04-28 | 2015-11-17 | The Procter & Gamble Company | Delivery particle |
| WO2012138710A2 (en) | 2011-04-07 | 2012-10-11 | The Procter & Gamble Company | Personal cleansing compositions with increased deposition of polyacrylate microcapsules |
| WO2012138696A2 (en) | 2011-04-07 | 2012-10-11 | The Procter & Gamble Company | Shampoo compositions with increased deposition of polyacrylate microcapsules |
| WO2012138690A2 (en) | 2011-04-07 | 2012-10-11 | The Procter & Gamble Company | Conditioner compositions with increased deposition of polyacrylate microcapsules |
| CN105061217A (zh) * | 2015-06-30 | 2015-11-18 | 徐静 | 枸橼酸舍曲林的2种晶型及其制备方法 |
| US12486478B2 (en) | 2020-10-16 | 2025-12-02 | The Procter & Gamble Company | Consumer products comprising delivery particles with high core:wall ratios |
| US12227720B2 (en) | 2020-10-16 | 2025-02-18 | The Procter & Gamble Company | Consumer product compositions with at least two encapsulate populations |
| CN116323893A (zh) | 2020-10-16 | 2023-06-23 | 宝洁公司 | 包含包封物群体的消费产品组合物 |
| CN112552188B (zh) * | 2020-12-17 | 2023-07-28 | 山西仟源医药集团股份有限公司 | 盐酸舍曲林晶型i的制备方法 |
| CN113588626B (zh) * | 2021-08-24 | 2024-05-24 | 上海师范大学 | 一种苯丙氨酸对映体的拉曼光谱检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| US5082970A (en) | 1991-03-06 | 1992-01-21 | Pfizer Inc. | Process for recycling amine isomer |
| GB9114947D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline |
| US5248699A (en) | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| US5734083A (en) | 1996-05-17 | 1998-03-31 | Torcan Chemical Ltd. | Sertraline polymorph |
| HU222341B1 (hu) | 1996-12-18 | 2003-06-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier |
| EP0928784B1 (en) | 1997-12-11 | 2002-06-12 | TORCAN CHEMICAL Ltd | Sertraline polymorph having improved water solubility |
| ES2217748T3 (es) | 1998-03-18 | 2004-11-01 | Ciba Specialty Chemicals Holding Inc. | Procedimiento para la hidrogenacin catalitica cis-selectiva de ciclohexilidenaminas. |
| JP2000026378A (ja) | 1998-07-03 | 2000-01-25 | Sumika Fine Chemicals Co Ltd | 塩酸セルトラリンの製法 |
| HK1040979A1 (zh) | 1998-11-27 | 2002-06-28 | Teva Pharmaceutical Industries Ltd. | 盐酸舍曲林多晶型物 |
| US6500987B1 (en) | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| ES2281374T3 (es) | 1999-12-21 | 2007-10-01 | Teva Pharmaceutical Industries Ltd. | Nuevos polimorfos de hidrocloruro de sertralina, procedimientos para su preparacion, composiciones que los contienen y metodos para su utilizacion. |
-
2000
- 2000-10-07 TW TW089120975A patent/TWI260315B/zh not_active IP Right Cessation
- 2000-10-20 MY MYPI20004969A patent/MY141509A/en unknown
- 2000-10-23 WO PCT/EP2000/010416 patent/WO2001032601A1/en not_active Ceased
- 2000-10-23 CN CN00815052A patent/CN1384816A/zh active Pending
- 2000-10-23 JP JP2001534755A patent/JP2003513062A/ja not_active Withdrawn
- 2000-10-23 AT AT00975896T patent/ATE409684T1/de not_active IP Right Cessation
- 2000-10-23 CA CA002387135A patent/CA2387135A1/en not_active Abandoned
- 2000-10-23 HU HU0203559A patent/HUP0203559A3/hu unknown
- 2000-10-23 IL IL14905000A patent/IL149050A0/xx active IP Right Grant
- 2000-10-23 TR TR2002/01146T patent/TR200201146T2/xx unknown
- 2000-10-23 AU AU13863/01A patent/AU1386301A/en not_active Abandoned
- 2000-10-23 US US10/111,947 patent/US6872853B1/en not_active Expired - Fee Related
- 2000-10-23 EP EP00975896A patent/EP1224160B1/en not_active Expired - Lifetime
- 2000-10-23 DE DE60040406T patent/DE60040406D1/de not_active Expired - Fee Related
- 2000-10-23 MX MXPA02004255A patent/MXPA02004255A/es active IP Right Grant
- 2000-10-27 AR ARP000105711A patent/AR026293A1/es not_active Application Discontinuation
-
2002
- 2002-04-09 IL IL149050A patent/IL149050A/en not_active IP Right Cessation
- 2002-04-24 ZA ZA200203254A patent/ZA200203254B/xx unknown
-
2003
- 2003-12-15 US US10/736,195 patent/US6939992B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6872853B1 (en) | 2005-03-29 |
| MXPA02004255A (es) | 2002-10-17 |
| AU1386301A (en) | 2001-05-14 |
| US20040132828A1 (en) | 2004-07-08 |
| MY141509A (en) | 2010-05-14 |
| EP1224160B1 (en) | 2008-10-01 |
| CN1384816A (zh) | 2002-12-11 |
| HUP0203559A3 (en) | 2008-01-28 |
| IL149050A (en) | 2007-03-08 |
| IL149050A0 (en) | 2002-11-10 |
| AR026293A1 (es) | 2003-02-05 |
| US6939992B2 (en) | 2005-09-06 |
| CA2387135A1 (en) | 2001-05-10 |
| TWI260315B (en) | 2006-08-21 |
| JP2003513062A (ja) | 2003-04-08 |
| ZA200203254B (en) | 2003-07-22 |
| HUP0203559A2 (hu) | 2003-03-28 |
| WO2001032601A1 (en) | 2001-05-10 |
| EP1224160A1 (en) | 2002-07-24 |
| DE60040406D1 (de) | 2008-11-13 |
| ATE409684T1 (de) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200201146T2 (tr) | Sertralin hidrokorid polimorfik formları. | |
| UY27304A1 (es) | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación | |
| PA8501801A1 (es) | Inhibidores triciclicos de polimerasas (adp - polirribosas) | |
| ES2112848T3 (es) | Nuevos derivados de la n-acil-2,3-benzodiazepina. | |
| BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
| ECSP056020A (es) | Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion | |
| PT915898E (pt) | Forma i cristalina de claritromicina | |
| HRP20010514B1 (en) | Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament | |
| ES2213732T3 (es) | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. | |
| BR0316375A (pt) | Diazinopirimidinas | |
| BR0111947A (pt) | Composto, composição farmacêutica, método para o tratamento de um distúrbio em um mamìfero, uso de um composto e processo para preparar, um composto | |
| CU23167A3 (es) | Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc | |
| AR040278A1 (es) | Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos | |
| DE69229339D1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| DE602006009619D1 (de) | Verfahren zur herstellung von 1-amino-3,5-dimethyladamantan-hydrochlorid | |
| AR036137A1 (es) | Sales novedosas de derivados anticonvulsivos | |
| AR024494A1 (es) | Proceso para la preparacion de derivados de ciclopentano sustituido y novedosas estructuras cristalinas de los mismos | |
| ECSP044973A (es) | Nuevas formas polimorficas cristalinas de clorhidrato de lercanidipina y proceso para su preparacion | |
| IT1319234B1 (it) | Processo di preparazione di gabapentina. | |
| ATE277039T1 (de) | Farnesyltransferase-inhibitoren die eine pyrrolstruktur haben und verfahren zu ihrer herstellung | |
| ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
| ES2185967T3 (es) | Procedimiento para preparar derivados acidos beta-amino-alfa-hidroxi. | |
| FI980530L (fi) | Menetelmä N-bis-(2-(1,2-dikarboksietoksi)-etyyli)amiinijohdannaisen va lmistamiseksi, menetelmällä saatavat tuotteet sekä niiden käytöt | |
| MY136360A (en) | Cyclohexane derivatives and methods for their preparation | |
| BR0010961A (pt) | Composto, composição farmacêutica, e, métodos para tratar epilepsia, ataques de tontura, hipocinésia, e distúrbios cranianos, distúrbios neurodegenerativos, depressão, ansiedade, pânico, dor, distúrbios neuropatológicos e distúrbios do sono |